Sandhill Capital Partners LLC Bio Techne Corp Transaction History

Sandhill Capital Partners LLC

$1.35 Billion
Q3 2024

A detailed history of Sandhill Capital Partners LLC transactions in Bio Techne Corp stock. As of the latest transaction made, Sandhill Capital Partners LLC holds 557,218 shares of TECH stock, worth $38.3 Million. This represents 3.3% of its overall portfolio holdings.

Number of Shares

557,218

Previous 569,881 2.22%

Holding current value

$38.3 Million

Previous $40.8 Million 9.05%

% of portfolio

3.3%

Previous 3.24%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$70.96 - $82.35 $898,566 - $1.04 Million	-12,663 Reduced 2.22%	557,218 $44.5 Million
Q2 2024 Aug 13, 2024	SELL	$62.12 - $84.15 $8.04 Million - $10.9 Million	-129,401 Reduced 18.5%	569,881 $40.8 Million
Q1 2024 May 14, 2024	BUY	$65.98 - $77.09 $566,306 - $661,663	8,583 Added 1.24%	699,282 $49.2 Million
Q4 2023 Feb 02, 2024	BUY	$52.83 - $78.22 $4.1 Million - $6.07 Million	77,638 Added 12.66%	690,699 $53.3 Million
Q3 2023 Nov 13, 2023	BUY	$67.52 - $89.42 $7.47 Million - $9.89 Million	110,614 Added 22.02%	613,061 $41.7 Million
Q2 2023 Aug 08, 2023	BUY	$73.76 - $85.98 $102,378 - $119,340	1,388 Added 0.28%	502,447 $41 Million
Q1 2023 May 12, 2023	BUY	$71.62 - $86.62 $35.9 Million - $43.4 Million	501,059 New	501,059 $37.2 Million
Q4 2022 Feb 10, 2023	BUY	$80.67 - $352.29 $28.1 Million - $123 Million	348,675 Added 291.36%	468,346 $38.8 Million
Q3 2022 Nov 14, 2022	BUY	$282.54 - $391.85 $6.3 Million - $8.73 Million	22,289 Added 22.89%	119,671 $34 Million
Q2 2022 Aug 10, 2022	SELL	$322.67 - $449.65 $4.05 Million - $5.65 Million	-12,557 Reduced 11.42%	97,382 $33.8 Million
Q1 2022 May 16, 2022	SELL	$353.85 - $487.79 $4.16 Million - $5.73 Million	-11,743 Reduced 9.65%	109,939 $47.6 Million
Q4 2021 Feb 09, 2022	BUY	$456.15 - $525.06 $311,550 - $358,615	683 Added 0.56%	121,682 $63 Million
Q3 2021 Nov 12, 2021	SELL	$444.87 - $538.88 $2.77 Million - $3.35 Million	-6,218 Reduced 4.89%	120,999 $58.6 Million
Q2 2021 Aug 11, 2021	SELL	$387.35 - $450.26 $220,014 - $255,747	-568 Reduced 0.44%	127,217 $57.3 Million
Q1 2021 May 13, 2021	SELL	$314.62 - $411.0 $3.49 Million - $4.55 Million	-11,079 Reduced 7.98%	127,785 $48.8 Million
Q4 2020 Feb 12, 2021	BUY	$246.9 - $321.87 $51,108 - $66,627	207 Added 0.15%	138,864 $44.1 Million
Q3 2020 Nov 12, 2020	SELL	$232.22 - $282.96 $5.96 Million - $7.26 Million	-25,654 Reduced 15.61%	138,657 $34.3 Million
Q2 2020 Aug 13, 2020	SELL	$185.43 - $279.56 $2.07 Million - $3.13 Million	-11,179 Reduced 6.37%	164,311 $43.4 Million
Q1 2020 May 14, 2020	BUY	$161.17 - $221.51 $232,568 - $319,638	1,443 Added 0.83%	175,490 $33.3 Million
Q4 2019 Feb 13, 2020	BUY	$189.68 - $222.09 $631,824 - $739,781	3,331 Added 1.95%	174,047 $38.2 Million
Q3 2019 Nov 14, 2019	BUY	$183.56 - $216.72 $729,834 - $861,678	3,976 Added 2.38%	170,716 $33.4 Million
Q2 2019 Aug 13, 2019	SELL	$188.72 - $215.43 $30.5 Million - $34.8 Million	-161,488 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$136.09 - $200.44 $22 Million - $32.4 Million	161,488 New	161,488 $32.1 Million
Q4 2018 Feb 13, 2019	SELL	$132.75 - $203.8 $20.9 Million - $32.1 Million	-157,557 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$147.44 - $204.11 $377,593 - $522,725	2,561 Added 1.65%	157,557 $32.2 Million
Q2 2018 Aug 13, 2018	BUY	$144.9 - $165.58 $586,845 - $670,599	4,050 Added 2.68%	154,996 $22.9 Million
Q1 2018 May 14, 2018	BUY	$131.46 - $151.04 $19.8 Million - $22.8 Million	150,946 New	150,946 $22.8 Million

Others Institutions Holding TECH

# of Institutions

601

Shares Held

151M

Call Options Held

195K

Put Options Held

53.2K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.7B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sandhill Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sandhill Capital Partners LLC with notifications on news.

Account

Sandhill Capital Partners LLC Bio Techne Corp Transaction History